Advertisement

Topics

Fluticasone furoate slows loss of lung function in COPD

11:00 EDT 4 Aug 2017 | Medical Xpress

(HealthDay)—Regular use of fluticasone furoate (FF), either alone or in combination with vilanterol (VI), appears to reduce the rate of forced expiratory volume in one second (FEV1) decline in patients with moderate chronic obstructive pulmonary disease (COPD) and a high risk of cardiovascular disease, according to a study published online July 24 in the American Journal of Respiratory and Critical Care Medicine.

Original Article: Fluticasone furoate slows loss of lung function in COPD

NEXT ARTICLE

More From BioPortfolio on "Fluticasone furoate slows loss of lung function in COPD"

Quick Search
Advertisement
 

Relevant Topics

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...